Table 2 Baseline characteristics of NAFLD patients with and without CVD.
Variables | Total N = 3129 | No-CVD N = 2406 | CVD N = 723 | P value |
---|---|---|---|---|
Gender* | Â | Â | Â | 0.003 |
Male | 2419 (77.31%) | 1890 (78.55%) | 529 (73.17%) | Â |
Female | 710 (22.69%) | 516 (21.45%) | 194 (26.83%) | Â |
Age(years)*# | 43.35 ± 11.07 | 42.24 ± 10.48 | 47.02 ± 12.15 | <0.001 |
< 40 | 1084 (34.64%) | 913 (37.9%) | 171 (23.65%) |  |
40–49 | 1339 (42.79%) | 1039 (43.18%) | 300 (41.49%) |  |
50–59 | 407 (13.01%) | 290 (12.05%) | 117 (16.18%) |  |
60–69 | 222 (7.09%) | 123 (5.11%) | 99 (13.69%) |  |
≥ 70 | 77 (2.46%) | 41 (1.70%) | 36 (4.98%) |  |
Diabetes* | 259 (8.28%) | 162 (6.73%) | 97 (13.42%) | < 0.001 |
Pre-diabetes* | 610 (19.50%) | 448 (18.62%) | 162 (22.41%) | 0.028 |
BMI(kg/m²)*# | 25.30 ± 2.83 | 25.11 ± 2.79 | 25.91 ± 2.87 | <0.001 |
<24 | 1033 (33.01%) | 846 (35.16%) | 187 (25.86%) | Â |
24–28 | 1591 (50.85%) | 1210 (50.29%) | 381 (52.70%) |  |
≥ 28 | 505 (16.14%) | 350 (14.54%) | 155 (21.44%) |  |
WC(cm)*# | 88.20 ± 8.52 | 87.89 ± 8.54 | 89.22 ± 8.38 | <0.001 |
Normal | 1444 (46.15%) | 1163 (48.34%) | 281 (38.87%) | Â |
Abnormal | 1685 (53.85%) | 1243 (51.66%) | 442 (61.13%) | Â |
SBP(mmHg)# | 120.02 ± 11.49 | 118.58 ± 11.56 | 124.80 ± 9.83 | <0.001 |
DBP(mmHg)# | 75.97 ± 7.61 | 75.02 ± 7.53 | 79.16 ± 6.96 | <0.001 |
BP(mmHg)* | Â | Â | Â | <0.001 |
<110/75 | 439 (14.03%) | 397 (16.50%) | 42 (5.81%) | Â |
110~<120/75~<80 | 710 (22.69%) | 615 (25.56%) | 95 (13.14%) | Â |
120~<130/80~<85 | 1055 (33.72%) | 813 (33.79%) | 242 (33.47%) | Â |
130~<140/85~<90 | 925 (29.56%) | 581 (24.15%) | 344 (47.58%) | Â |
TC(mmol/L)*# | 4.82 ± 0.91 | 4.78 ± 0.89 | 4.95 ± 0.97 | <0.001 |
Normal | 2891 (92.39%) | 2239 (93.06%) | 652 (90.18%) | 0.013 |
Abnormal | 238 (7.61%) | 167 (6.94%) | 71 (9.82%) | Â |
TG(mmol/L)*# | 2.52 ± 1.86 | 2.45 ± 1.72 | 2.77 ± 2.24 | < 0.001 |
Normal | 1070 (34.20%) | 848 (35.25%) | 222 (30.71%) | 0.027 |
Abnormal | 2059 (65.80%) | 1558 (64.75%) | 501 (69.29%) | Â |
HDL-C(mmol/L)* | 1.22 ± 0.28 | 1.22 ± 0.28 | 1.23 ± 0.31 | 0.441 |
Normal | 2212 (70.69%) | 1726 (71.74%) | 486 (67.22%) | 0.022 |
Abnormal | 917 (29.31%) | 680 (28.26%) | 237 (32.8%) | Â |
Metabolic syndrome* | 954(30.49%) | 657(27.31%) | 297(41.07%) | < 0.001 |
NFS* | Â | Â | Â | <0.001 |
<-1.455 | 2114(67.56%) | 1698 (70.57%) | 416 (57.54%) | Â |
-1.455-0.676 | 949(30.33%) | 670 (27.85%) | 279 (38.58%) | Â |
≥ 0.676 | 66(2.11%) | 38 (1.58%) | 28 (3.87%) |  |